Lower Limb ExoNET: Development and Evaluation for Gait Assistance With Stroke Survivors
NCT ID: NCT06999213
Last Updated: 2025-07-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
EARLY_PHASE1
20 participants
INTERVENTIONAL
2026-01-31
2029-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Feasibility of ExoNET
NCT05180812
Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors
NCT06655636
Mobility Training Using Exoskeletons for Functional Recovery After Stroke
NCT02128152
Robotic Exoskeleton Assisted Gait Post Stroke
NCT04309305
Therapeutic Effects of Robotic Exoskeleton-Assisted Gait Re-habilitation and Predictive Factors of Significant Improvements in Stroke Patients
NCT05825144
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Participants will receive Sham → Assist → Resist in a crossover design.
Assist
The device will provide assistive torques to support either ankle, knee, and/or hip movements.
Resist
The device will apply resistive torques to exaggerate gait asymmetries, facilitating error augmentation.
Slack
The device will be worn but will not generate any torque.
Group 2
Participants will receive Sham → Resist → Assist in a crossover design
Assist
The device will provide assistive torques to support either ankle, knee, and/or hip movements.
Resist
The device will apply resistive torques to exaggerate gait asymmetries, facilitating error augmentation.
Slack
The device will be worn but will not generate any torque.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Assist
The device will provide assistive torques to support either ankle, knee, and/or hip movements.
Resist
The device will apply resistive torques to exaggerate gait asymmetries, facilitating error augmentation.
Slack
The device will be worn but will not generate any torque.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to provide informed consent
* Capable of ambulating without the use of assistive devices for 2 hours
Exclusion Criteria
* Pregnant
* Severe medical diagnoses (e.g. cardiovascular, orthopedic)
* Skin allergies or irritation; open wounds
* Prisoners
* Cognitively impaired adults
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shirley Ryan AbilityLab
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
James Lanphier Patton
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
James L Patton, PhD
Role: PRINCIPAL_INVESTIGATOR
Shirley Ryan AbilityLab
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STU00223221
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.